Advertisement

Topics

AGTC Files Investigational New Drug Application For The Treatment Of X-Linked Retinitis Pigmentosa Caused By Mutations In The RPGR Gene

20:00 EDT 9 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: AGTC Files Investigational New Drug Application For The Treatment Of X-Linked Retinitis Pigmentosa Caused By Mutations In The RPGR Gene

NEXT ARTICLE

More From BioPortfolio on "AGTC Files Investigational New Drug Application For The Treatment Of X-Linked Retinitis Pigmentosa Caused By Mutations In The RPGR Gene"

Quick Search
Advertisement